Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 35 citing articles:

Immunogenicity and protective efficacy of a multi-antigenic adenovirus-based vaccine candidate against Mycobacterium tuberculosis
Jin-Seung Yun, Eunkyung Shin, Young-Ran Lee, et al.
Frontiers in Microbiology (2025) Vol. 16
Open Access | Times Cited: 1
A century of BCG: Impact on tuberculosis control and beyond
Asma Ahmed, Srabanti Rakshit, Vasista Adiga, et al.
Immunological Reviews (2021) Vol. 301, Iss. 1, pp. 98-121
Open Access | Times Cited: 53
It Takes a Village: The Multifaceted Immune Response to Mycobacterium tuberculosis Infection and Vaccine-Induced Immunity
Sasha E. Larsen, Brittany D. Williams, Maham Rais, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 34
A review of the BCG vaccine and other approaches toward tuberculosis eradication
Thomas Cho, Christopher Khatchadourian, Nguyễn Đức Huy, et al.
Human Vaccines & Immunotherapeutics (2021) Vol. 17, Iss. 8, pp. 2454-2470
Open Access | Times Cited: 30
BCGΔBCG1419c increased memory CD8+ T cell-associated immunogenicity and mitigated pulmonary inflammation compared with BCG in a model of chronic tuberculosis
Kee Woong Kwon, Michel de Jesús Aceves-Sánchez, Cristian Alfredo Segura-Cerda, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 19
Immunological effects of the PE/PPE family proteins of Mycobacterium tuberculosis and related vaccines
Fangzheng Guo, Jing Wei, Yamin Song, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Tuberculosis Vaccines and T Cell Immune Memory
Fei Li, Wenrui Dang, Yunjie Du, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 483-483
Open Access | Times Cited: 4
A temperature-responsive PLA-based nanosponge as a novel nanoadjuvant and efficient delivery carrier of Ag85B for effective vaccine against Mycobacterium tuberculosis
Jin-Seung Yun, Soo-Min Kim, Jin Sil Lee, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access
Developing New Anti-Tuberculosis Vaccines: Focus on Adjuvants
Ana Rita Franco, Francesco Peri
Cells (2021) Vol. 10, Iss. 1, pp. 78-78
Open Access | Times Cited: 26
Prophylactic efficacy against Mycobacterium tuberculosis using ID93 and lipid-based adjuvant formulations in the mouse model
Susan L. Baldwin, Valerie A. Reese, Sasha E. Larsen, et al.
PLoS ONE (2021) Vol. 16, Iss. 3, pp. e0247990-e0247990
Open Access | Times Cited: 26
BCG-booster vaccination with HSP90-ESAT-6-HspX-RipA multivalent subunit vaccine confers durable protection against hypervirulent Mtb in mice
Kee Woong Kwon, Han‐Gyu Choi, Kwang Sung Kim, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 3
Immunological Characterization of Proteins Expressed by Genes Located in Mycobacterium tuberculosis-Specific Genomic Regions Encoding the ESAT6-like Proteins
Abu Salim Mustafa
Vaccines (2021) Vol. 9, Iss. 1, pp. 27-27
Open Access | Times Cited: 23
Subunit vaccine protects against a clinical isolate of Mycobacterium avium in wild type and immunocompromised mouse models
Sasha E. Larsen, Valerie A. Reese, Tiffany Pecor, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 22
Protective Efficacy and Immunogenicity of Rv0351/Rv3628 Subunit Vaccine Formulated in Different Adjuvants Against Mycobacterium tuberculosis Infection
Kee Woong Kwon, Tae Gun Kang, Ara Lee, et al.
Immune Network (2023) Vol. 23, Iss. 2
Open Access | Times Cited: 8
Immunogenicity and protective efficacy of RipA, a peptidoglycan hydrolase, against Mycobacterium tuberculosis Beijing outbreak strains
Kee Woong Kwon, Han‐Gyu Choi, Hong‐Hee Choi, et al.
Vaccine (2024) Vol. 42, Iss. 8, pp. 1941-1952
Closed Access | Times Cited: 3
Rescuing ESAT-6 Specific CD4 T Cells From Terminal Differentiation Is Critical for Long-Term Control of Murine Mtb Infection
Helena Strand Clemmensen, Niels Peter Hell Knudsen, Rolf Billeskov, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 22
Tuberculosis vaccine developments and efficient delivery systems: A comprehensive appraisal
Rasoul Hoseinpour, Alka Hasani, Behzad Baradaran, et al.
Heliyon (2024) Vol. 10, Iss. 4, pp. e26193-e26193
Open Access | Times Cited: 2
Transcriptional Profiling of Human Peripheral Blood Mononuclear Cells Stimulated by Mycobacterium tuberculosis PPE57 Identifies Characteristic Genes Associated With Type I Interferon Signaling
Fanli Yi, Jing Hu, Xiaoyan Zhu, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 15
Therapeutic efficacy against Mycobacterium tuberculosis using ID93 and liposomal adjuvant formulations
Susan L. Baldwin, Valerie A. Reese, Sasha E. Larsen, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 11
Early Secreted Antigenic Target of 6 Kda-Like Proteins of Mycobacterium tuberculosis
Abu Salim Mustafa
International Journal of Mycobacteriology (2022) Vol. 11, Iss. 1, pp. 10-15
Open Access | Times Cited: 9
Optimizing the Boosting Schedule of Subunit Vaccines Consisting of BCG and “Non-BCG” Antigens to Induce Long-Term Immune Memory
Wei Lv, Pu He, Yanlin Ma, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 9
In-vivo expressed Mycobacterium tuberculosis antigens recognised in three mouse strains after infection and BCG vaccination
Mariateresa Coppola, Fabienne Jurion, Susan J. F. van den Eeden, et al.
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 11
Host‐directed anti‐mycobacterial activity of colchicine, an anti‐gout drug, via strengthened host innate resistance reinforced by the IL‐1β/PGE2 axis
Kee Woong Kwon, Lee‐Han Kim, Soon Myung Kang, et al.
British Journal of Pharmacology (2022) Vol. 179, Iss. 15, pp. 3951-3969
Open Access | Times Cited: 8
Role of MHC class I pathways in Mycobacterium tuberculosis antigen presentation
Karolina D. Witt
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 4
Adjunctive administration of parabiotic Lactobacillus sakei CVL-001 ameliorates drug-induced toxicity and pulmonary inflammation during antibiotic treatment for tuberculosis
Hagyu Kim, Eun-Jung Song, Eunsol Choi, et al.
International Immunopharmacology (2024) Vol. 132, pp. 111937-111937
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top